Welcome to “Who Got the Work?℠,” a weekly column that highlights the law firms and lawyers who are being brought in to handle key California cases and close major deals for their clients.

In this week’s column, suits claiming asthma medication cause severe neuropsychiatric  changes land in California federal court; a handful of toxic chemical suits target major corporations; and a personal injury attorney lawyers up in response to a scam fintech company using her image for its website and social media accounts.

Singulair Suits Inflate in California Federal Court

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]